Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Sarcoma, Kaposi × Nevirapine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Kaposi 1 Acquired Immunodeficiency Syndrome 1

Interventions

pembrolizumab 3 Nivolumab 2 Filgrastim 2 Docetaxel 2 valspodar 1 talimogene laherparepvec 1 liposomal doxorubicin 1 lenvatinib 1 fialuridine 1 etoposide phosphate 1 efineptakin alfa 1 X-Rays 1 Thalidomide 1 Sunitinib 1 SUB1 protein, human 1 Ritonavir 1 Propranolol 1 Peripheral Blood Stem Cell Transplantation 1 Nevirapine 1 Nelfinavir 1 Maraviroc 1 Lopinavir 1 Indinavir 1 Ifosfamide 1 Gemcitabine 1 Etoposide 1 Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 1 Emtricitabine 1 Diagnostic Tests, Routine 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00380770 2010-07-21

KAART

University of KwaZulu

Phase 4 Completed

Acquired Immunodeficiency Syndrome, Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon ⚡